
novartis international ag
Novartis Launches Blood Cancer Drug, Jakavi®
Jakavi, the only approved oral medication for the blood cancer myelofibrosis, has been introduced in Singapore and 50 other countries.

5 Take-Home Points From India’s Historic Novartis Patent Case
The Indian Supreme Court ruling dismissing a patent application by Novartis for a new version of its leukemia drug raises five important points, writes Arvind Subramanian.
Novartis Loses Historic India Patent Case On Cancer Drug Glivec
After a seven year protracted battle, the Supreme Court of India has rejected a patent application by Swiss pharma giant Novartis for an updated version of its blockbuster drug.
Novartis To Build US$500m Biotech Facility In Singapore
Novartis announced today the construction of a new state-of-the-art biotechnology facility in Singapore with an investment valued at over US$500 million.
OPINION: India Mustn’t Bow To Patent Pressure
The latest round of challenges to India's drug patent laws is a fight that must be won for the world's poor, says Priya Shetty.
India’s Patent Laws Threaten Public Health, U.K. Experts
Pending cases against India's patent laws threaten public health and misinterpret international IP agreements, say two public health experts from the U.K.
Interleukin-5 Jab Offers Hope For Treating Autoimmune Disease
Research into treatments for autoimmune diseases may have received a booster shot as interleukin-5 injections show promise in regulating the body's immune system.
Coalition Aims To Eradicate 10 Neglected Tropical Diseases By 2020
A large coalition of pharmas, governments, and NGOs have announced their goal of eliminating or controlling 10 neglected tropical diseases by 2020.